Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)MBSRforIBDNCT07266883
A Mindfulness-based Stress Reduction Program for IBD
A study testing Mindfulness based stress reduction in people with Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis), run by Nova Scotia Health Authority at 1 site in Canada.
Trial summary
The gut-brain connection is important for good health and when it is disrupted it can worsen existing chronic disease. Studies have shown that chronic stress has negative effects on the gastrointestinal tract such as inflammation and disruption of the beneficial bacteria that live there. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
- What is being tested?
- Mindfulness based stress reduction
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteCanada
- Study dates
- 1 Sep 2027to 1 Feb 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18 years of age or older
- having a known diagnosis of IBD that is mildly to moderately active
Who cannot join
- Pediatric participants
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site
QEII Health Sciences Centre
Halifax, Nova Scotia, B3H 2Y9
Jennifer Jones, MD, FRCPC, 902-473-1499, jljones@dal.ca
Jennifer Jones, MD, FRCPC
About this study
Official title: Targeting the Brain-gut Axis in Inflammatory Bowel Diseases: Implementation and Exploration of Mechanism and Early Effectiveness of a Mindfulness-based Stress Reduction Program
The gut-brain connection is important for good health and when it is disrupted it can worsen existing chronic disease. Studies have shown that chronic stress has negative effects on the gastrointestinal tract such as inflammation and disruption of the beneficial bacteria that live there. These negative effects of chronic stress can lead to flare-ups of IBD. Mindfulness-based stress reduction (MBSR) is a structured 8 week program that aims to reduce stress by teaching mindfulness techniques. Recent research in people living with IBD suggests that MBSR could improve one's quality of life by reducing stress levels. The study aims to investigate the effects of MBSR on both the mental health of people living with IBD, and their physical health. The investigators are studying people who are participating in an MBSR program as well as those receiving standard of care at the QEII Health Sciences Centre. This study will assess how effective the MBSR program is compared to standard of care at reducing distress and signs of stress and inflammation in people living with IBD. This study aims to provide valuable insights into how mindfulness techniques could be used to support individuals living with IBD. Ultimately, this research aims to improve quality of life and health outcomes for people affected by this challenging condition.
Read the detailed description
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic immune-mediated diseases that affect the gastrointestinal tract most often diagnosed in the second and third decades of life. IBD can have a deleterious impact on one's personal life, work and career trajectory, and mental and physical health over time. Untreated, IBD often leads to significant impairments in quality of life related to the effect of the disease on both mental and physical health. More than 30 percent of people living with IBD are also struggling with some form of psychological distress (PD) at any given time, which may be a result of the disease or independent of IBD. Forms of PD include, but are not limited to, anxiety, depression, and disease-related stress. Although psychotherapy interventions have been the main focus for management of psychological distress in IBD, a growing body of literature focusing on mindfulness-based interventions (MBIs) in IBD exists. MBI interventions focus on the development of greater capacity for "awareness that arises through paying attention, on purpose, in the present moment, non-judgementally." Greater capacity to default to present moment awareness rather than a future focus, specifically, excessive worrying (fuels anxiety) or backward gazing, specifically ruminating (predisposes to depression) has the potential to significantly improve chronic disease-related distress in persons living with IBD. One of the most well-defined, evidence-based MBIs is a structured, standardized, 8-week curriculum focused on experiential learning and mindfulness practices called mindfulness-based stress reduction (MBSR). Despite the promise of MBSR, many questions remain unanswered. Variability in IBD patient populations studied, the nature and severity of psychological distress, outcome measures, study design, and overall lack of mechanistic research in IBD are all gaps in existing research that need to be addressed. The benefit of MBSR to target the brain-gut axis and as an adjunctive therapy is also unclear. The Nova Scotia Collaborative IBD Program is running an 8-week MBSR program for people in Nova Scotia living with IBD. With this prospective observational cohort study, the investigators plan to evaluate how effective this program is in improving quality of life and reducing stress biomarkers and psychological stress scores for adult patients with IBD. This study will compare health outcomes of patients who participated in an MBSR program run by qualified MBSR teachers affiliated with the NSCIBD to a group of patients who have received standard of care. The overall objectives of this study are to: 1. Evaluate the early effectiveness of the 8-week MBSR program and 2. Collect and analyze biological and microbial markers of systemic and intestinal inflammation to understand MBSR-mediated psychological, disease-related, immunologic, neurohormonal, and microbiome impacts in persons living with mild to moderately active IBD compared to controls. This will be an open-label, comparator-controlled study in which patients with IBD will undergo random allocation to either standard of care + a stress reduction educational video or standard of care + an 8 week MBSR program (MBSR-IBD). MBSR is a skills-based, experiential learning program in which participants attend weekly 2.5 hour sessions for 8 weeks plus one full day weekend session. Over the course of these sessions, participants learn mindfulness-based skills including, but not limited to, formal and informal meditation. Inclusion criteria include participants 18 years of age or older and a known diagnosis of mild to moderately active IBD. Health outcome data on clinical disease activity, microbial diversity, and cytokine arrays will be prospectively collected. Psychological questionnaires will also be collected. Data on disease activity, duration, phenotype, as well as medication and surgical history will be collected via targeted chart review.
- Being tested
- Mindfulness based stress reduction, Active Control
- Keywords
- IBD, psychological distress, mindfulness
- Medical subject headings
- Inflammatory Bowel Diseases, Colitis, Ulcerative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mindfulness based stress reductionBehavioural
A mindfulness based stress reduction (MBSR) course. Participants will complete this course, which will have weekly sessions over Zoom (group format) over 8 weeks. Homework exercises will also be part of the course.
Active ControlOther
Educational stress reduction video
| Study group | Role | What they receive |
|---|---|---|
| MBSR group | Experimental | Will participate in an 8 week mindfulness-based stress reduction course, administered by a trained professional (clinician), virtually (zoom) with sessions once weekly and homework exercises. Group format. Receives: Behavioral: Mindfulness based stress reduction |
| Active Control | Active comparator | Will be asked to watch an educational video on stress reduction Receives: Other: Active Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Psychological distress (GAD7)
Participant psychological distress, measured by the Generalized Anxiety Disorder Assessment (GAD7) scale. Score ranges from 0-21. Higher scores are worse.
Measured: Visit 1 (2 months post enrollment)
Psychological distress (GAD7)
Participant psychological distress, measured by the Generalized Anxiety Disorder Assessment (GAD7) scale. Score ranges from 0-21. Higher scores are worse.
Measured: Visit 2 (6 months post enrollment)
Psychological distress (PHQ9)
Participant psychological distress, measured by the nine-item Patient Health Questionnaire (PHQ9). This questionnaire measures depression symptom severity. Score range: 0 to 27. Higher scores indicate more severe depressive symptoms.
Measured: Visit 1 (2 months post enrollment)
Psychological distress (PHQ9)
Participant psychological distress, measured by the nine-item nine-item Patient Health Questionnaire-9 (PHQ-9). This questionnaire measures depression symptom severity. Score range: 0 to 27. Higher scores indicate more severe depressive symptoms.
Measured: Visit 2 (6 months post enrollment)
IBD-related quality of life score (SIBDQ)
IBD-related quality of life score, measured by the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Score range: 10 to 70. Higher scores indicate better quality of life
Measured: Visit 1 (2 months post enrollment)
IBD-related quality of life score (SIBDQ)
IBD-related quality of life score, measured by the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Score range: 10 to 70. Higher scores indicate better quality of life.
Measured: Visit 2 (6 months post enrollment)
General quality of life score (SF-36)
General quality of life score, measured by the SF-36 questionnaire. The summary scores range from 0 to 100. Higher scores indicate better perceived health/functioning.
Measured: Visit 1 (2 months post enrollment)
General quality of life score (SF-36)
General quality of life score, measured by the SF-36 questionnaire. The summary scores range from 0 to 100. Higher scores indicate better perceived health/functioning.
Measured: Visit 2 (6 months post enrollment)
Secondary outcomes (14)
Mindfulness (FFMQ)
Participant mindfulness, measured by the Five Facet Mindfulness Questionnaire (FFMQ). The 39-item FFMQ total score ranges from 39 to 195, with higher scores indicating greater dispositional mindfulness.
Measured: Visit 1 (2 months post enrollment)
Mindfulness (FFMQ)
Participant mindfulness, measured by the Five Facet Mindfulness Questionnaire (FFMQ). The 39-item FFMQ total score ranges from 39 to 195, with higher scores indicating greater dispositional mindfulness.
Measured: Visit 2 (6 months post enrollment)
Resilience (CD-RISC)
Participant psychological resilience, measured by the Connor-Davidson Resilience Scale (CD-RISC). Total scores range from 0 to 100, with higher scores indicating greater resilience.
Measured: Visit 1 (2 months post enrollment)
Resilience (CD-RISC)
Participant psychological resilience, measured by the Connor-Davidson Resilience Scale (CD-RISC). Total scores range from 0 to 100, with higher scores indicating greater resilience.
Measured: Visit 2 (6 months post enrollment)
Participant self-efficacy score (NGSE Scale)
Self-efficacy, measured by the New General Self-Efficacy Scale. Score range: 10 to 40 (each item scored 1-4). Higher scores indicate greater self-efficacy.
Measured: Visit 1 (2 months post enrollment)
Participant Self efficacy score (NGSE Scale)
Self-efficacy, measured by the New General Self Efficacy Scale (NGSE Scale). Score range: 10 to 40 (each item scored 1-4). Higher scores indicate greater self-efficacy.
Measured: Visit 2 (6 months post enrollment)
Psychological Flexibility (compACT)
Participant psychological flexibility, measured by the Comprehensive assessment of Acceptance and Commitment Therapy processes (CompACT) scale. Score range: 0 to 92 (items scored on a 5-point scale with some reverse-scored. Higher scores indicate greater psychological flexibility (a strength).
Measured: Visit 1 (2 months post enrollment)
Psychological Flexibility (compACT)
Participant psychological flexibility, measured by the Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT). Score range: 0 to 92 (items scored on a 5-point scale with some reverse-scored. Higher scores indicate greater psychological flexibility (a strength).
Measured: Visit 2 (6 months post enrollment)
Participant Fatigue (FACIT-F)
Participant fatigue as measured by the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) Scale. Total scores range from 0 to 52, with higher scores indicating less fatigue and better functioning
Measured: Visit 1 (2 months post enrollment)
Participant Fatigue (FACIT-F)
Participant fatigue as measured by the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) Scale. Total scores range from 0 to 52, with higher scores indicating less fatigue and better functioning.
Measured: Visit 2 (6 months post enrollment)
Fecal microbial diversity
Participant fecal microbial diversity, measured as laboratory based estimates of alpha diversity, beta-diversity, from processed fecal samples. Higher alpha diversity values are generally associated with greater microbial richness and ecological stability. Beta diversity reflects differences in microbial community composition between samples and is interpreted relative to comparator groups.
Measured: Visit 1 (8 weeks post enrollment)
Fecal microbial diversity
Participant fecal microbial diversity, measured as laboratory based estimates of alpha diversity, beta-diversity, from processed fecal samples.Higher alpha diversity values are generally associated with greater microbial richness and ecological stability. Beta diversity reflects differences in microbial community composition between samples and is interpreted relative to comparator groups.
Measured: Visit 2 (6 months post enrollment)
Fecal microbial abundance
Participant fecal microbial abundance, measured as laboratory-based estimates of relative abundance of individual amplicon sequence variants (ASVs) from processed fecal samples. Relative abundance values reflect the proportional representation of specific taxa within the microbial community and are interpreted in the context of the specific organism identified.
Measured: Visit 1 (2 months post enrollment)
Fecal microbial abundance
Participant fecal microbial abundance, measured as laboratory-based estimates of relative abundance of individual amplicon sequence variants (ASVs)from processed fecal samples. Relative abundance values reflect the proportional representation of specific taxa within the microbial community and are interpreted in the context of the specific organism identified.
Measured: Visit 2 (6 months post enrollment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2025
- Study start1 Sep 2027 (estimated)
- Primary completion1 Feb 2028 (estimated)
- Study completion1 Feb 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Nova Scotia Health Authority
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07266883
- Sponsor's protocol ID
- 75285
- Acronym
- MBSRforIBD
- Status last verified
- Sep 2026
- First submitted
- 10 Sep 2025
- Last updated
- 8 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Targeting the Brain-gut Axis in Inflammatory Bowel Diseases: Implementation and Exploration of Mechanism and Early Effectiveness of a Mindfulness-based Stress Reduction Program
- ClinicalTrials.gov ID
- NCT07266883
- Acronym / sponsor ID
- MBSRforIBD / 75285
- Keywords
- IBD, psychological distress, mindfulness
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Nova Scotia Health AuthorityUniversity, hospital or other
- Study start
- 1 Sep 2027 (estimated)
- Primary completion
- 1 Feb 2028 (estimated)
- Study completion
- 1 Feb 2028 (estimated)
- First posted
- 5 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The gut-brain connection is important for good health and when it is disrupted it can worsen existing chronic disease. Studies have shown that chronic stress has negative effects on the gastrointestinal tract such as inflammation and disruption of the beneficial bacteria that live there. These negative effects of chronic stress can lead to flare-ups of IBD. Mindfulness-based stress reduction (MBSR) is a structured 8 week program that aims to reduce stress by teaching mindfulness techniques. Recent research in people living with IBD suggests that MBSR could improve one's quality of life by reducing stress levels. The study aims to investigate the effects of MBSR on both the mental health of people living with IBD, and their physical health. The investigators are studying people who are participating in an MBSR program as well as those receiving standard of care at the QEII Health Sciences Centre. This study will assess how effective the MBSR program is compared to standard of care at reducing distress and signs of stress and inflammation in people living with IBD. This study aims to provide valuable insights into how mindfulness techniques could be used to support individuals living with IBD. Ultimately, this research aims to improve quality of life and health outcomes for people affected by this challenging condition.
Detailed description
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic immune-mediated diseases that affect the gastrointestinal tract most often diagnosed in the second and third decades of life. IBD can have a deleterious impact on one's personal life, work and career trajectory, and mental and physical health over time. Untreated, IBD often leads to significant impairments in quality of life related to the effect of the disease on both mental and physical health. More than 30 percent of people living with IBD are also struggling with some form of psychological distress (PD) at any given time, which may be a result of the disease or independent of IBD. Forms of PD include, but are not limited to, anxiety, depression, and disease-related stress. Although psychotherapy interventions have been the main focus for management of psychological distress in IBD, a growing body of literature focusing on mindfulness-based interventions (MBIs) in IBD exists. MBI interventions focus on the development of greater capacity for "awareness that arises through paying attention, on purpose, in the present moment, non-judgementally." Greater capacity to default to present moment awareness rather than a future focus, specifically, excessive worrying (fuels anxiety) or backward gazing, specifically ruminating (predisposes to depression) has the potential to significantly improve chronic disease-related distress in persons living with IBD. One of the most well-defined, evidence-based MBIs is a structured, standardized, 8-week curriculum focused on experiential learning and mindfulness practices called mindfulness-based stress reduction (MBSR). Despite the promise of MBSR, many questions remain unanswered. Variability in IBD patient populations studied, the nature and severity of psychological distress, outcome measures, study design, and overall lack of mechanistic research in IBD are all gaps in existing research that need to be addressed. The benefit of MBSR to target the brain-gut axis and as an adjunctive therapy is also unclear. The Nova Scotia Collaborative IBD Program is running an 8-week MBSR program for people in Nova Scotia living with IBD. With this prospective observational cohort study, the investigators plan to evaluate how effective this program is in improving quality of life and reducing stress biomarkers and psychological stress scores for adult patients with IBD. This study will compare health outcomes of patients who participated in an MBSR program run by qualified MBSR teachers affiliated with the NSCIBD to a group of patients who have received standard of care. The overall objectives of this study are to: 1. Evaluate the early effectiveness of the 8-week MBSR program and 2. Collect and analyze biological and microbial markers of systemic and intestinal inflammation to understand MBSR-mediated psychological, disease-related, immunologic, neurohormonal, and microbiome impacts in persons living with mild to moderately active IBD compared to controls. This will be an open-label, comparator-controlled study in which patients with IBD will undergo random allocation to either standard of care + a stress reduction educational video or standard of care + an 8 week MBSR program (MBSR-IBD). MBSR is a skills-based, experiential learning program in which participants attend weekly 2.5 hour sessions for 8 weeks plus one full day weekend session. Over the course of these sessions, participants learn mindfulness-based skills including, but not limited to, formal and informal meditation. Inclusion criteria include participants 18 years of age or older and a known diagnosis of mild to moderately active IBD. Health outcome data on clinical disease activity, microbial diversity, and cytokine arrays will be prospectively collected. Psychological questionnaires will also be collected. Data on disease activity, duration, phenotype, as well as medication and surgical history will be collected via targeted chart review.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| MBSR group | Experimental | Behavioral: Mindfulness based stress reductionWill participate in an 8 week mindfulness-based stress reduction course, administered by a trained professional (clinician), virtually (zoom) with sessions once weekly and homework exercises. Group format. |
| Active Control | Active comparator | Other: Active ControlWill be asked to watch an educational video on stress reduction |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- 18 years of age or older
- having a known diagnosis of IBD that is mildly to moderately active
Key exclusion criteria (1 listed)
- Pediatric participants
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mindfulness based stress reductionA mindfulness based stress reduction (MBSR) course. Participants will complete this course, which will have weekly sessions over Zoom (group format) over 8 weeks. Homework exercises will also be part of the course. | Behavioural | MBSR group |
| Active ControlEducational stress reduction video | Other | Active Control |
Primary outcome
Psychological distress (GAD7)
Time frame: Visit 1 (2 months post enrollment)
Participant psychological distress, measured by the Generalized Anxiety Disorder Assessment (GAD7) scale. Score ranges from 0-21. Higher scores are worse.
Psychological distress (GAD7)
Time frame: Visit 2 (6 months post enrollment)
Participant psychological distress, measured by the Generalized Anxiety Disorder Assessment (GAD7) scale. Score ranges from 0-21. Higher scores are worse.
Psychological distress (PHQ9)
Time frame: Visit 1 (2 months post enrollment)
Participant psychological distress, measured by the nine-item Patient Health Questionnaire (PHQ9). This questionnaire measures depression symptom severity. Score range: 0 to 27. Higher scores indicate more severe depressive symptoms.
Psychological distress (PHQ9)
Time frame: Visit 2 (6 months post enrollment)
Participant psychological distress, measured by the nine-item nine-item Patient Health Questionnaire-9 (PHQ-9). This questionnaire measures depression symptom severity. Score range: 0 to 27. Higher scores indicate more severe depressive symptoms.
IBD-related quality of life score (SIBDQ)
Time frame: Visit 1 (2 months post enrollment)
IBD-related quality of life score, measured by the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Score range: 10 to 70. Higher scores indicate better quality of life
IBD-related quality of life score (SIBDQ)
Time frame: Visit 2 (6 months post enrollment)
IBD-related quality of life score, measured by the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Score range: 10 to 70. Higher scores indicate better quality of life.
General quality of life score (SF-36)
Time frame: Visit 1 (2 months post enrollment)
General quality of life score, measured by the SF-36 questionnaire. The summary scores range from 0 to 100. Higher scores indicate better perceived health/functioning.
General quality of life score (SF-36)
Time frame: Visit 2 (6 months post enrollment)
General quality of life score, measured by the SF-36 questionnaire. The summary scores range from 0 to 100. Higher scores indicate better perceived health/functioning.
14 secondary outcomes
Mindfulness (FFMQ)
Time frame: Visit 1 (2 months post enrollment)
Mindfulness (FFMQ)
Time frame: Visit 2 (6 months post enrollment)
Resilience (CD-RISC)
Time frame: Visit 1 (2 months post enrollment)
Resilience (CD-RISC)
Time frame: Visit 2 (6 months post enrollment)
Participant self-efficacy score (NGSE Scale)
Time frame: Visit 1 (2 months post enrollment)
Participant Self efficacy score (NGSE Scale)
Time frame: Visit 2 (6 months post enrollment)
Psychological Flexibility (compACT)
Time frame: Visit 1 (2 months post enrollment)
Psychological Flexibility (compACT)
Time frame: Visit 2 (6 months post enrollment)
Participant Fatigue (FACIT-F)
Time frame: Visit 1 (2 months post enrollment)
Participant Fatigue (FACIT-F)
Time frame: Visit 2 (6 months post enrollment)
Fecal microbial diversity
Time frame: Visit 1 (8 weeks post enrollment)
Fecal microbial diversity
Time frame: Visit 2 (6 months post enrollment)
Fecal microbial abundance
Time frame: Visit 1 (2 months post enrollment)
Fecal microbial abundance
Time frame: Visit 2 (6 months post enrollment)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Recruiting
Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)
Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Active, not recruiting
Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study
Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis), Fecal Microbiota Transplantation
Not yet recruiting
Impact of a Human Origin Heat Inactivated Probiotic-Lactobacillus Paracasei D3.5 (LpD3.5) as Dietary Supplement on Gut Mucin and Intestinal Permeability in Adults With IBD
Inflammatory Bowel Diseases
Recruiting
Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life
Inflammatory Bowel Disease (IBD), Medication Compliance
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mindfulness based stress reduction in people with Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis), run by Nova Scotia Health Authority at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 8 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jennifer Jones, MD, FRCPC (902-473-1499, jljones@dal.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Psychological distress (GAD7) (time frame: Visit 1 (2 months post enrollment)). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2026.